PNC Financial Services Group’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,543
Closed -$23K 5318
2025
Q4
$23K Sell
2,543
-462
-15% -$3.45K ﹤0.01% 3602
2025
Q3
$9.35K Hold
3,005
﹤0.01% 3969
2025
Q2
$6.43K Buy
3,005
+1,036
+53% +$1.67K ﹤0.01% 4037
2025
Q1
$2.26K Buy
1,969
+1,935
+5,691% +$3.32K ﹤0.01% 4306
2024
Q4
$74 Hold
34
﹤0.01% 4722
2024
Q3
$74 Hold
34
﹤0.01% 4734
2024
Q2
$79 Buy
34
+9
+36% +$37 ﹤0.01% 4724
2024
Q1
$138 Buy
25
+20
+400% +$91 ﹤0.01% 4636
2023
Q4
$12 Buy
+5
New +$47 ﹤0.01% 4605
2023
Q2
Sell
-52
Closed -$1.74K 4841
2023
Q1
$1.74K Hold
52
﹤0.01% 4343
2022
Q4
$1.71K Hold
52
﹤0.01% 4300
2022
Q3
$2K Sell
52
-142
-73% -$3.14K ﹤0.01% 4222
2022
Q2
$2K Buy
+194
New +$2.9K ﹤0.01% 4246

Other funds holding VTYX

PNC Financial Services Group's VTYX Position: Q1 2026 in Review

PNC Financial Services Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 2,543 shares — an estimated $23K sold.

PNC Financial Services Group first reported a position in VTYX in Q2 2022 and held it in 13 quarters. The position peaked at $23K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • PNC Financial Services Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 2,543 Ventyx Biosciences shares in Q1 2026, an estimated $23K.
  • PNC Financial Services Group first reported a position in Ventyx Biosciences in Q2 2022 and held it in 13 quarters.
  • PNC Financial Services Group's Ventyx Biosciences position peaked at $23K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.